This site is intended for healthcare professionals only
LoginRegister
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopeniaCDSCO Panel Recommends Protocol Amendment for Novartis' Ianalumab Trial
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealEli Lilly Gets CDSCO Panel Nod To import, and market anticancer Selpercatinib Tablets
Torrent Pharma appoints Aman Mehta as MDThird-Gen Leadership: Aman Mehta set to lead Torrent Pharma as MD
Medtonic to invest nearly Rs 430 crore in new diabetes GCC in PuneMedtronic to spin off diabetes business
medicineNeurotrophin peptidomimetic drugs offer promise for treating neurodegenerative disorders, finds...
Bayer gets UK nod for Lynkuet for moderate to severe vasomotor symptoms associated with menopauseBayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with hemophilia A
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s diseaseUSFDA Advisory Committee reviews Roche Columvi Combo for diffuse large B-cell Lymphoma
Biocon Biologics Yesafili gets Health Canada nod for eye diseasesBiocon Biologics commercial partner launches psoriatic arthritis injection in Japan
Bharat Biotech Oral Cholera vaccine Hillchol​ shows success in Phase III clinical studiesBharat Biotech Oral Cholera vaccine Hillcholl shows success in Phase III studies
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug SoaanzUSFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz
Regulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult DataZydus Lifesciences gets CDSCO Panel nod to study Aprepitant powder for Oral Suspension
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialAstraZeneca Pharma India gets CDSCO Panel nod for Anti-cancer Drug Osimertinib Tablets 40 mg and 80...
X